China MediaExpress Holdings (CME), a television advertising operator on inter-city express buses, has signed a three-year exclusive agreement to provide television programming and advertisements on all 32 express buses originating from the Qingdao Liuting International Airport (Qingdao Airport).

Nexstar Broadcasting Group has reported net revenue of $73.96m for the fourth quarter ended December 31, 2009, a decrease of 7.9 percent, compared to $80.31m, for the same period in 2008.

Reed's, a maker of sodas in natural food stores, and Jones Soda have entered into a letter of intent (LoI) regarding a merger, with Reed's as the surviving company. The combination would unite a number of soda brands, such as Reed's Ginger Brew, Virgil's, and Jones Soda.

Pizza Inn has opened its new buffet-style restaurant at 6801 SW 3rd Street in Oklahoma City. The new restaurant is the company's third in Oklahoma City and fourteenth in the state.

Jacobs Engineering Group has received a two-year contract from Canaport LNG for the provision of maintenance and related services at the company's LNG Terminal in Saint John, New Brunswick, Canada.

Jacobs Engineering Group has bagged a contract from the Air Force Research Laboratory's Airbase Technologies Division to perform research and development of technologies for deployed airbase infrastructure, force protection and homeland defense operations.

Financial services firm Stone & Youngberg Holdings, together with Stone & Youngberg LLC, has announced key promotions across all areas of the firm, including its municipal sales & trading group, portfolio strategy group, public finance group, taxable group, private client group, and municipal credit group.

FHN Hospital has selected ProVation Order Sets, powered by UpToDate Decision Support, from Wolters Kluwer Health to automate the creation, deployment and maintenance of order sets.

Navistar International Corporation has reported sales and revenues of $2.8 billion for the fiscal first quarter ended January 31, 2010, compared to $2.97 billion for the comparable period in 2009.

Abbott and Facet Biotech have signed a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline. The acquisition brings access to biologics in two key therapeutic areas, immunology and oncology.